747 related articles for article (PubMed ID: 22489794)
21. Dose-intense phase II study of weekly cisplatin and epidoxorubicin plus medroxyprogesterone acetate and recombinant interleukin 2 in stage IIIB-IV non-small cell lung cancer.
Mantovani G; Macciò A; Mulas C; Massa E; Madeddu C; Mura L; Contu P; Versace R
Oncol Rep; 2002; 9(3):661-70. PubMed ID: 11956647
[TBL] [Abstract][Full Text] [Related]
22. Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.
Reck M; von Pawel J; Macha HN; Kaukel E; Deppermann KM; Bonnet R; Ulm K; Hessler S; Gatzemeier U
Lung Cancer; 2006 Jul; 53(1):67-75. PubMed ID: 16713013
[TBL] [Abstract][Full Text] [Related]
23. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
Wakelee HA; Bernardo P; Johnson DH; Schiller JH
Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
[TBL] [Abstract][Full Text] [Related]
24. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
Meek CL; Wallace AM; Forrest LM; McMillan DC
Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
[TBL] [Abstract][Full Text] [Related]
25. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer.
Widder J; Postmus D; Ubbels JF; Wiegman EM; Langendijk JA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e291-7. PubMed ID: 21640503
[TBL] [Abstract][Full Text] [Related]
26. [Inflammatory markers, nutritional parameters and polyunsaturated fatty acids in hemodialysis patients].
Perunicić-Peković GB; Pljesa SI; Rasić ZR; Stanković SD; Ilić MN
Med Pregl; 2007; 60 Suppl 2():43-7. PubMed ID: 18928156
[TBL] [Abstract][Full Text] [Related]
27. Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis.
Krause L; Becker MO; Brueckner CS; Bellinghausen CJ; Becker C; Schneider U; Haeupl T; Hanke K; Hensel-Wiegel K; Ebert H; Ziemer S; Ladner UM; Pirlich M; Burmester GR; Riemekasten G
Ann Rheum Dis; 2010 Nov; 69(11):1951-7. PubMed ID: 20511612
[TBL] [Abstract][Full Text] [Related]
28. Parenteral nutrition support for patients with pancreatic cancer--improvement of the nutritional status and the therapeutic outcome.
Richter E; Denecke A; Klapdor S; Klapdor R
Anticancer Res; 2012 May; 32(5):2111-8. PubMed ID: 22593497
[TBL] [Abstract][Full Text] [Related]
29. Personalized peptide vaccination in patients with refractory non-small cell lung cancer.
Yoshiyama K; Terazaki Y; Matsueda S; Shichijo S; Noguchi M; Yamada A; Mine T; Ioji T; Itoh K; Shirouzu K; Sasada T; Takamori S
Int J Oncol; 2012 May; 40(5):1492-500. PubMed ID: 22307435
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of bioelectrical impedance phase angle in advanced cancer: preliminary observations.
Santarpia L; Marra M; Montagnese C; Alfonsi L; Pasanisi F; Contaldo F
Nutrition; 2009 Sep; 25(9):930-1. PubMed ID: 19500944
[TBL] [Abstract][Full Text] [Related]
31. Malnutrition and impaired muscle strength in patients with Crohn's disease and ulcerative colitis in remission.
Valentini L; Schaper L; Buning C; Hengstermann S; Koernicke T; Tillinger W; Guglielmi FW; Norman K; Buhner S; Ockenga J; Pirlich M; Lochs H
Nutrition; 2008; 24(7-8):694-702. PubMed ID: 18499398
[TBL] [Abstract][Full Text] [Related]
32. The phase angle of the electrical impedance is a predictor of long-term survival in dialysis patients.
Abad S; Sotomayor G; Vega A; Pérez de José A; Verdalles U; Jofré R; López-Gómez JM
Nefrologia; 2011; 31(6):670-6. PubMed ID: 22130282
[TBL] [Abstract][Full Text] [Related]
33. Objective Score of Nutrition on Dialysis (OSND) as an alternative for the malnutrition-inflammation score in assessment of nutritional risk of haemodialysis patients.
Beberashvili I; Azar A; Sinuani I; Yasur H; Feldman L; Averbukh Z; Weissgarten J
Nephrol Dial Transplant; 2010 Aug; 25(8):2662-71. PubMed ID: 20190238
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of circulating chromogranin A and soluble tumor necrosis factor receptors in advanced nonsmall cell lung cancer.
Gregorc V; Spreafico A; Floriani I; Colombo B; Ludovini V; Pistola L; Bellezza G; Viganò MG; Villa E; Corti A
Cancer; 2007 Aug; 110(4):845-53. PubMed ID: 17599769
[TBL] [Abstract][Full Text] [Related]
35. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
36. The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.
Carey MS; Bacon M; Tu D; Butler L; Bezjak A; Stuart GC
Gynecol Oncol; 2008 Jan; 108(1):100-5. PubMed ID: 17920108
[TBL] [Abstract][Full Text] [Related]
37. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of health-related quality of life for overall survival in elderly non-small-cell lung cancer patients.
Fiteni F; Vernerey D; Bonnetain F; Vaylet F; Sennélart H; Trédaniel J; Moro-Sibilot D; Herman D; Laizé H; Masson P; Derollez M; Clément-Duchêne C; Milleron B; Morin F; Zalcman G; Quoix E; Westeel V
Eur J Cancer; 2016 Jan; 52():120-8. PubMed ID: 26682871
[TBL] [Abstract][Full Text] [Related]
39. Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial.
Sánchez-Lara K; Turcott JG; Juárez-Hernández E; Nuñez-Valencia C; Villanueva G; Guevara P; De la Torre-Vallejo M; Mohar A; Arrieta O
Clin Nutr; 2014 Dec; 33(6):1017-23. PubMed ID: 24746976
[TBL] [Abstract][Full Text] [Related]
40. Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation.
Farias CL; Campos DJ; Bonfin CM; Vilela RM
Clin Nutr; 2013 Jun; 32(3):420-5. PubMed ID: 23149161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
